UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:September 28,
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more aTyr Pharma Charts.
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more aTyr Pharma Charts.

Atyr Pharma Inc News

aTyr Pharma to Present at Upcoming Investor Conferences
Monday 6 May 2024 (2 days ago) • GlobeNewswire Inc.
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
Friday 3 May 2024 (5 days ago) • GlobeNewswire Inc.
aTyr Pharma to Participate in April Investor Conferences
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
Friday 15 March 2024 (2 months ago) • GlobeNewswire Inc.
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
Thursday 22 February 2024 (3 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
Tuesday 30 January 2024 (3 months ago) • GlobeNewswire Inc.
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
Friday 19 January 2024 (4 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 10 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 10 January 2024 (4 months ago) • Edgar (US Regulatory)

More Atyr Pharma Inc News Articles